These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11604028)

  • 1. Prediction of enzyme binding: human thrombin inhibition study by quantum chemical and artificial intelligence methods based on X-ray structures.
    Mlinsek G; Novic M; Hodoscek M; Solmajer T
    J Chem Inf Comput Sci; 2001; 41(5):1286-94. PubMed ID: 11604028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
    Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
    J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling.
    Steinmetzer T; Baum B; Biela A; Klebe G; Nowak G; Bucha E
    ChemMedChem; 2012 Nov; 7(11):1965-73. PubMed ID: 22907907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies.
    Weir MP; Bethell SS; Cleasby A; Campbell CJ; Dennis RJ; Dix CJ; Finch H; Jhoti H; Mooney CJ; Patel S; Tang CM; Ward M; Wonacott AJ; Wharton CW
    Biochemistry; 1998 May; 37(19):6645-57. PubMed ID: 9578548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounds binding to the S2-S3 pockets of thrombin.
    Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
    J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.
    Maryanoff BE; Qiu X; Padmanabhan KP; Tulinsky A; Almond HR; Andrade-Gordon P; Greco MN; Kauffman JA; Nicolaou KC; Liu A
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8048-52. PubMed ID: 8367461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study.
    Casale E; Collyer C; Ascenzi P; Balliano G; Milla P; Viola F; Fasano M; Menegatti E; Bolognesi M
    Biophys Chem; 1995 Mar; 54(1):75-81. PubMed ID: 7703351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
    Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.
    Nicolotti O; Giangreco I; Miscioscia TF; Convertino M; Leonetti F; Pisani L; Carotti A
    J Comput Aided Mol Des; 2010 Feb; 24(2):117-29. PubMed ID: 20148287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxyanion-mediated inhibition of serine proteases.
    Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
    Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of thrombin-ecotin reveals conformational changes and extended interactions.
    Wang SX; Esmon CT; Fletterick RJ
    Biochemistry; 2001 Aug; 40(34):10038-46. PubMed ID: 11513582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionality map analysis of the active site cleft of human thrombin.
    Grootenhuis PD; Karplus M
    J Comput Aided Mol Des; 1996 Feb; 10(1):1-10. PubMed ID: 8786410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition.
    Mlinsek G; Novic M; Kotnik M; Solmajer T
    J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.